Advertisement

Table of Contents

January 01, 1982; Volume 21,Issue 1

You have access
Subunit selectivity in the monooxygenase-like activity of tetrameric hemoglobin.
B L Ferraiolo and J J Mieyal

Molecular Pharmacology January 1982, 21 (1) 1-4;
You have access
Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.
A De Lean, A A Hancock and R J Lefkowitz

Molecular Pharmacology January 1982, 21 (1) 5-16;
You have access
Alpha 2-adrenergic receptors in neuroblastoma x glioma hybrid cells. Characterization with agonist and antagonist radioligands and relationship to adenylate cyclase.
D J Kahn, J C Mitrius and D C U'Prichard

Molecular Pharmacology January 1982, 21 (1) 17-26;
You have access
Regulation of autonomic receptors in rat submandibular gland.
D B Bylund, J R Martinez and D L Pierce

Molecular Pharmacology January 1982, 21 (1) 27-35;
You have access
Apparent "down-regulation" of human platelet alpha 2-adrenergic receptors is due to retained agonist.
J S Karliner, H J Motulsky and P A Insel

Molecular Pharmacology January 1982, 21 (1) 36-43;
You have access
Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
M W Hamblin and I Creese

Molecular Pharmacology January 1982, 21 (1) 44-51;
You have access
Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.
M W Hamblin and I Creese

Molecular Pharmacology January 1982, 21 (1) 52-56;
You have access
Kinetics of [3H]flunitrazepam binding to membrane-bound benzodiazepine receptors.
T H Chiu, D M Dryden and H C Rosenberg

Molecular Pharmacology January 1982, 21 (1) 57-65;
You have access
Muscarinic cholinergic receptors on cultured thyroid cells. I. Biological effect of carbachol and characterization of the receptors.
S Champion and J Mauchamp

Molecular Pharmacology January 1982, 21 (1) 66-72;
You have access
Muscarinic cholinergic receptors on cultured thyroid cells. II. Carbachol-induced desensitization.
S Champion and J Mauchamp

Molecular Pharmacology January 1982, 21 (1) 73-77;
You have access
Human polymorphonuclear neutrophils. Pharmacological characterization of histamine receptors mediating the elevation of cyclic AMP.
C Gespach and J P Abita

Molecular Pharmacology January 1982, 21 (1) 78-85;
You have access
Interaction of beta-endorphin and other opioid peptides with calmodulin.
M Sellinger-Barnette and B Weiss

Molecular Pharmacology January 1982, 21 (1) 86-91;
You have access
Study of the interaction between human serum albumin and some cephalosporins.
C Briand, M Sarrazin, V Peyrot, R Gilli, M Bourdeaux and J C Sari

Molecular Pharmacology January 1982, 21 (1) 92-99;
You have access
Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study.
V Maes, Y Engelborghs, J Hoebeke, Y Maras and A Vercruysse

Molecular Pharmacology January 1982, 21 (1) 100-107;
You have access
Characterization of S-adenosylhomocysteine binding to isolated rat hepatocytes and purified rat liver plasma membranes. Effect of analogues of S-adenosylhomocysteine.
P M Ueland, J Aarbakke and A Bessesen

Molecular Pharmacology January 1982, 21 (1) 108-113;
You have access
The autoreceptor control of dopamine synthesis. An in vitro and in vivo comparison of dopamine agonists.
D R Haubrich and A B Pflueger

Molecular Pharmacology January 1982, 21 (1) 114-120;
You have access
Rat parotid gland protein kinase activation. Relationship to enzyme secretion.
T N Spearman and F R Butcher

Molecular Pharmacology January 1982, 21 (1) 121-127;
You have access
Alpha1-adrenergic stimulation of phosphatidylinositol-phosphatidic acid turnover in rat parotid cells.
T Uchida, H Ito, B J Baum, G S Roth, C R Filburn and B Sacktor

Molecular Pharmacology January 1982, 21 (1) 128-132;
You have access
Metabolism of N-alkyl compounds during the biosynthesis of prostaglandins. N-Dealkylation during prostaglandin biosynthesis.
K Sivarajah, J M Lasker, T E Eling and M B Abou-Donia

Molecular Pharmacology January 1982, 21 (1) 133-141;
You have access
Inhibition of prostaglandin synthesis antagonizes the colchicine-induced reduction of vasopressin-stimulated water flow in the toad urinary bladder.
R M Burch and P V Halushka

Molecular Pharmacology January 1982, 21 (1) 142-149;
You have access
The influence of organometals on heme metabolism. In vivo and in vitro studies with organotins.
D W Rosenberg, G S Drummond and A Kappas

Molecular Pharmacology January 1982, 21 (1) 150-158;
You have access
Suicide inactivation of hamster hepatic arylhydroxamic acid N,O-acyltransferase. A selective probe of N-acetyltransferase multiplicity.
P E Hanna, R B Banks and V C Marhevka

Molecular Pharmacology January 1982, 21 (1) 159-165;
You have access
Further studies of the suicide inactivation of purified rat liver cytochrome P-450 by chloramphenicol.
J Halpert

Molecular Pharmacology January 1982, 21 (1) 166-172;
You have access
Aromatase enzyme catalysis is involved in the potent inhibition of estrogen biosynthesis caused by 4-acetoxy- and 4-hydroxy-4-androstene-3, 17-dione.
D F Covey and W F Hood

Molecular Pharmacology January 1982, 21 (1) 173-180;
You have access
Inhibition of calf thymus and rat hypothalamic synaptosomal protein carboxymethyltransferase by analogues of S-adenosylhomocysteine.
R T Borchardt, D Kuonen, J A Huber and A Moorman

Molecular Pharmacology January 1982, 21 (1) 181-186;
You have access
Ames test and antitumor activity of 1-(X-phenyl)-3,3-dialkyltriazenes. Quantitative structure-activity studies based upon molecular shape analysis.
A J Hopfinger and R Potenzone

Molecular Pharmacology January 1982, 21 (1) 187-195;
You have access
The antitumor effects of anthracyclines. II. The stereospecificity of the carbomethoxy group at position 10 of the class II anthracycline molecule.
V H DuVernay, D Eubanks, R Perales, A W Prestayko and S T Crooke

Molecular Pharmacology January 1982, 21 (1) 196-203;
You have access
Biochemical and cell cycle perturbations in methotrexate-treated cells.
I W Taylor, P Slowiaczek, P R Francis and M H Tattersall

Molecular Pharmacology January 1982, 21 (1) 204-210;
You have access
Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
H A Ingraham, B Y Tseng and M Goulian

Molecular Pharmacology January 1982, 21 (1) 211-216;
You have access
Antiviral, antimetabolic, and cytotoxic activities of 5-substituted 2'-deoxycytidines.
E De Clercq, J Balzarini, J Descamps, G F Huang, P F Torrence, D E Bergstrom, A S Jones, P Serafinowski, G Verhelst and R T Walker

Molecular Pharmacology January 1982, 21 (1) 217-223;
You have access
Biochemical interactions between N-(phosphonacetyl)-L-aspartate and 5-fluorouracil.
C M Liang, R C Donehower and B A Chabner

Molecular Pharmacology January 1982, 21 (1) 224-230;
You have access
Properties of dihydrofolate reductase from a methotrexate-resistant subline of human KB cells and comparison with enzyme from KB parent cells and mouse S180 AT/3000 cells.
B A Domin, Y C Cheng and M T Hakala

Molecular Pharmacology January 1982, 21 (1) 231-238;
You have access
Epidermis: a site of drug metabolism in neonatal rat skin. Studies on cytochrome P-450 content and mixed-function oxidase and epoxide hydrolase activity.
D R Bickers, T Dutta-Choudhury and H Mukhtar

Molecular Pharmacology January 1982, 21 (1) 239-247;
You have access
Monoclonal antibodies to rabbit liver cytochrome P-450LM2 and cytochrome P-450LM4.
S S Park, S J Cha, H Miller, A V Persson, M J Coon and H V Gelboin

Molecular Pharmacology January 1982, 21 (1) 248-258;